Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 192,115 | 86,511 | 396,831 | 280,142 | 190,314 |
| Depreciation Amortization | 69,453 | 34,410 | 135,913 | 24,583 | 65,199 |
| Income taxes - deferred | -29,956 | -15,000 | -41,163 | -29,273 | -10,112 |
| Accounts receivable | -3,038 | -8,483 | -25,603 | -28,274 | -22,158 |
| Accounts payable and accrued liabilities | 5,347 | 5,865 | 361 | -4,288 | 6,224 |
| Other Working Capital | 3,561 | 30,991 | -20,864 | -41,693 | -27,791 |
| Other Operating Activity | 62,149 | 30,246 | 146,916 | 210,499 | 76,992 |
| Operating Cash Flow | $299,631 | $164,540 | $592,391 | $411,696 | $278,668 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -20,000 | 0 | -65,275 | -64,693 | -53,484 |
| PPE Investments | -11,725 | -3,574 | -9,687 | -8,410 | -6,028 |
| Net Acquisitions | N/A | N/A | -1,502,443 | -1,502,443 | N/A |
| Purchase Sale Intangibles | -2,000 | N/A | -173,750 | -173,750 | -158,750 |
| Other Investing Activity | -2,000 | 0 | -173,750 | -173,750 | -158,750 |
| Investing Cash Flow | $-33,725 | $-3,574 | $-1,751,155 | $-1,749,296 | $-218,262 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 994,647 | 994,777 | N/A |
| Debt Repayment | -368,047 | -159,023 | -178,304 | -19,282 | -19,282 |
| Common Stock Issued | 19,071 | 5,676 | 24,174 | 17,951 | 14,611 |
| Common Stock Repurchased | -30,859 | -13,896 | -278,296 | -259,819 | -163,244 |
| Other Financing Activity | -16,320 | -14,431 | -21,234 | -20,595 | -14,278 |
| Financing Cash Flow | $-396,155 | $-181,674 | $540,987 | $713,032 | $-182,193 |
| Exchange Rate Effect | 3,499 | 1,740 | -5,045 | 2,350 | 968 |
| Beginning Cash Position | 365,963 | 365,963 | 988,785 | 988,785 | 988,785 |
| End Cash Position | 239,213 | 346,995 | 365,963 | 366,567 | 867,966 |
| Net Cash Flow | $-126,750 | $-18,968 | $-622,822 | $-622,218 | $-120,819 |
| Free Cash Flow | |||||
| Operating Cash Flow | 299,631 | 164,540 | 592,391 | 411,696 | 278,668 |
| Capital Expenditure | -11,725 | -3,574 | -9,687 | -8,410 | -6,028 |
| Free Cash Flow | 287,906 | 160,966 | 582,704 | 403,286 | 272,640 |